NASDAQ · ENSG
The Ensign Group, Inc.
$186.32+$2.21 (+1.2%)
The Ensign Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.53% below the high.
Loading market information…
NYSE · EHC · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Encompass Health Corporation’s quoted price sits in the upper half of its reported 52-week range, 1.69% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Encompass Health Corporation’s forward annual dividend is $0.84 per share, paid quarterly. The forward yield is 0.64% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Encompass Health Corporation’s next earnings report is currently expected on Feb 4, 2027, with estimated earnings per share of $1.58. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Encompass Health Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:40 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 | Aug 5, 2025 | $1.40+13.82% vs estimate | $1.46B+2.13% vs estimate |
|---|
| Q1 2025 | Apr 24, 2025 | $1.37+15.13% vs estimate | $1.46B+1.8% vs estimate |
|---|
| Q4 2024 | Feb 6, 2025 | $1.17+11.43% vs estimate | $1.41B+1.72% vs estimate |
|---|
THE ANALYST VIEW
27 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 5 contributors · Median target $151.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$186.32+$2.21 (+1.2%)
The Ensign Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.53% below the high.
$49.68+$0.62 (+1.26%)
PACS Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.39% below the high.
$541.92+$8.56 (+1.6%)
Chemed Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.61% below the high.
$31.85+$0.56 (+1.79%)
Option Care Health, Inc.’s quoted price sits in the upper half of its reported 52-week range, 13.45% below the high.
$212.16+$0.37 (+0.17%)
National HealthCare Corporation’s quoted price sits in the upper half of its reported 52-week range, 14.52% below the high.
$13.26+$0.20 (+1.53%)
Aveanna Healthcare Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 9.86% below the high.
$124.34+$2.16 (+1.77%)
Addus HomeCare Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.92% below the high.
$42.48+$0.32 (+0.76%)
The Pennant Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.14% below the high.
